Annual report pursuant to Section 13 and 15(d)

Goodwill (Details)

v3.20.1
Goodwill (Details)
12 Months Ended
Dec. 31, 2019
USD ($)
reporting_unit
Dec. 31, 2018
USD ($)
Goodwill [Roll Forward]    
Beginning Balance $ 14,409,088 $ 12,290,247
Goodwill from acquisitions   3,778,001
Goodwill purchase price allocation measurement period adjustment from acquisition of TRx Pharmaceuticals   (1,659,160)
Ending Balance $ 14,409,088 14,409,088
Number of reporting units | reporting_unit 1  
Accumulated impairment of goodwill $ 0 0
Pediatric Portfolio | Discontinued Operations, Disposed of by Sale    
Goodwill [Roll Forward]    
Percentage of goodwill allocated to Pediatric Portfolio 12.20%  
Allocation of goodwill to divested Pediatric Portfolio   $ 2,000,000